Revenue Cycle

Defining 'integral' tricky for self-administered drugs

Briefings on APCs, February 1, 2012

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on APCs.

Self-administered drugs present a significant issue for coders, especially when considering how they may or may not be covered by Medicare Part B. In many instances, payers may consider a drug to be self-administered in some circumstances but not in others. As a result, coders must pay special attention to how these drugs are used within their setting.

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on APCs.

    Recovery Auditor Report
  • Recovery Auditor Report

    The Recovery Auditor Report is a free biweekly e-newsletter of useful tips and strategies to get you prepared for the...

  • Medicare Update for CAHs

    Medicare Update for CAHs is a free bi-weekly ezxne that provides specialized information for our CAH (critical access...

Most Popular

Related Articles